Insider · CIK 0001968317
Raju Prasad
cfoofficer
Files at CRSP (CRISPR Therapeutics AG). First filing Mar 18, 2025, latest Mar 24, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $248k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRSP: CRISPR Therapeutics AG
CRSPOct 9, 2026 · close 53.39
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | CRISPR Therapeutics AG | $91k 2,197 shares | -12% | - | |
| 38Weak | CRISPR Therapeutics AG | $157k 3,762 shares | -23% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 20,000 | Jun 3, 2025 |
| Mar 20, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +6,250 | - | - | 18,964 | Mar 24, 2025 |
| Mar 21, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -2,197 | $41.23 | $91k | 16,767 | Mar 24, 2025 |
| Mar 20, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -6,250 | - | - | 18,750 | Mar 24, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +10,000 | - | - | 16,476 | Mar 18, 2025 |
| Mar 17, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -3,762 | $41.80 | $157k | 12,714 | Mar 18, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -10,000 | - | - | 20,000 | Mar 18, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +36,666 | $0.00 | $0 | 36,666 | Mar 18, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +27,500 | $0.00 | $0 | 27,500 | Mar 18, 2025 |
| Oct 16, 2024 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +18,333 | $0.00 | $0 | 18,333 | Oct 18, 2024 |
| Oct 16, 2024 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +15,000 | $0.00 | $0 | 15,000 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.